Studies have shown that an NF-κB inhibitor, DHMEQ, inhibited the migration and invasion of human endometriosis stromal cells, and DHMEQ is particularly effective in suppressing disease models by intraperitoneal administration [32]. The gene discussed is NFKB1; the disease is endometriosis.